U.S. Semiconductors Stock News

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

CDT Environmental Technology Investment Holdings Limited ( NASDAQ:CDTG ) shares have had a really impressive month...

With a median price-to-sales (or "P/S") ratio of close to 9.9x in the Biotechs industry in the United States, you could...

Ever get the feeling you are about to make a move on a stock but wish you had a little more context? You are not alone. Investors eyeing Tri Pointe Homes these days are definitely asking themselves if it is time to buy in, hang tight, or look elsewhere. This homebuilder’s stock has made some impressive long-term gains, up a remarkable 123.2% over the past three years and still 78.7% higher than five years ago. But if you have been watching only the short term, it's been a bumpy ride, with the...

Earlier this week, the U.S. administration introduced substantial new tariffs, imposing a 50% duty on imported kitchen cabinets and bathroom vanities and a 30% tariff on upholstered furniture to bolster domestic manufacturing. These trade measures are expected to improve the position of U.S. manufacturers such as American Woodmark by narrowing the price gap with foreign competitors. We'll explore how the new tariffs could shift American Woodmark's competitive landscape and affect its future...

On September 26, 2025, Fractyl Health announced results from the REMAIN-1 Midpoint Cohort, showing that its Revita treatment helped patients maintain additional weight loss after discontinuing GLP-1 drugs, while control group patients experienced weight regain. This data supports the potential for Revita as the first therapy designed to preserve weight loss post-GLP-1 treatment and boosts confidence in Fractyl Health's ongoing pivotal study, which is progressing toward key regulatory...

If you’ve been tracking VanEck ETF Trust, VanEck Gold Miners ETF (ARCA:GDX), you know something is up. Gold is on pace for its second-best run in fifty years, reportedly rising over 43% as investors respond to a mix of global uncertainty and shifting monetary policies. This kind of rally has brought gold mining ETFs like GDX into the spotlight, with many watching closely as institutional investors still seem hesitant to pile in. China’s continued heavy gold imports, aiming to diversify and...

Earlier this week, GoPro unveiled the MAX2 360 camera featuring True 8K resolution and launched new AI-powered editing tools including the GoPro ReFrame plugin for DaVinci Resolve, expanding integration with top professional editing platforms. This marks GoPro's most significant push yet to enhance its hardware and software ecosystem, aiming to empower both professionals and hobbyists in widescale 360 content creation. We'll examine how the MAX2 launch and new AI-driven editing innovations...

If you have been tracking Cracker Barrel Old Country Store (CBRL) lately, this week probably caught your eye. Things took a sharp turn when activist investor Biglari Capital filed a preliminary proxy statement urging shareholders to withhold votes from two board members and vote against several management-backed measures. Add in new earnings guidance, fourth-quarter results, a fresh dividend affirmation, and news of a $100 million share buyback, and there is no shortage of talking points for...

If you have ever stared at Franklin Resources stock and wondered whether now is the time to act, you are certainly not alone. This is a name that gets plenty of investor attention, especially after a year of strong gains and a recent streak of volatility. The stock has jumped 15.5% year-to-date and climbed 19.0% over the past twelve months. However, the past month told a different story, with a dip of 9.2%. Weekly performance is also in the red, down 4.7% over the last seven days. A longer...

Ares Capital recently experienced share price pressure as investors await its upcoming earnings report, which is expected to show year-over-year declines in both earnings and revenue. This caution is further highlighted by a neutral analyst outlook and unchanged earnings estimates amid underperformance compared to major market indices. We’ll explore how anticipation around the forthcoming earnings release shapes Ares Capital’s investment narrative and investor sentiment. The best AI stocks...

Thinking about buying, selling, or holding Cipher Mining stock? You are definitely not alone. The buzz around this name has been hard to miss, especially with its wild ride over the past year. Those returns have been nothing short of eye-catching. While the shares stumbled a bit in the last week and dipped 6.6%, zoom out and the story looks very different: up over 64% in the last month, 137.5% year-to-date, and an incredible 179.1% in the past 12 months. If you stretch even further back,...

FS KKR Capital (FSK) just closed a significant $400 million public offering of 6.125% unsecured notes, set to mature in 2031. This move is not just another funding exercise; it is a calculated step to boost the company’s financial flexibility and give FS KKR Capital more breathing room for corporate priorities. This could include paying down existing debt or positioning for future investments. As investors review the headlines, this new batch of notes is likely raising deeper questions about...

Earlier this month, Cassava Sciences President and CEO Richard Barry made a significant personal investment by acquiring 237,941 shares valued at US$534,743 following the discontinuation of the company’s Alzheimer’s drug program due to disappointing clinical trial results. This marked Barry’s first insider purchase in over a year and is being interpreted as a sign of confidence in Cassava’s remaining pipeline and future direction, as the company focuses on new opportunities including a...

MicroAlgo (NasdaqCM:MLGO) just scored a highly visible milestone by being added to the S&P Global BMI Index. If you have been following the company, you already know that this sort of index inclusion can bring in fresh attention from institutional investors and fund managers. For those on the fence about the stock, the big question now is whether this event is a game-changer or just another headline in a volatile year. This development comes after a string of mixed returns for MicroAlgo, with...

If you’ve been following PepGen (PEPG), the latest clinical update might have you rethinking your next move. The company just released results from the 15 mg/kg cohort of its FREEDOM-DM1 Phase 1 study for myotonic dystrophy type 1, showing progress for its investigational candidate, PGN-EDODM1. With plans to expand its trials in the coming quarters, PepGen is clearly pushing its development pipeline forward. News like this often attracts investor attention when positive data is...

If you've been watching Ocugen (OCGN) lately, you probably noticed the company just inked an exclusive licensing deal with Kwangdong Pharmaceutical, granting rights to its lead gene therapy, OCU400, in South Korea. This agreement is more than just a headline, with the potential for millions in upfront cash and milestone payments, plus steady sales-based revenue on the table. For a clinical-stage biotech, especially one advancing a therapy for retinitis pigmentosa, a disease with no current...

On September 24, 2025, RedCloud Holdings plc announced it has joined the NVIDIA Connect program, enabling its development teams to access NVIDIA's advanced AI frameworks and resources to accelerate innovation in global trade solutions. This initiative reinforces RedCloud’s commitment to leveraging cutting-edge technology to tackle the $2 trillion global inventory gap impacting the $14.6 trillion global FMCG industry. We'll explore how RedCloud’s adoption of NVIDIA’s AI capabilities could...

Blue Owl Capital (OBDC) made waves this week as company leadership took the spotlight at the 3rd Annual AI Summit, placing a bold emphasis on artificial intelligence initiatives. This isn’t just a casual mention; Blue Owl is actively signaling to investors and the industry that it plans to address technological disruption head-on. The focus on AI, delivered by Principal and Chief of Staff Jared Sheiker at the summit, suggests a pivot toward strategies that could redefine its future growth and...

Earlier this week, Cardlytics saw increased public attention after Citron Research released a report highlighting the company's potential upside if it secures a major customer for its rewards platform. This analysis by Citron points to the potential for Cardlytics to transform its business model and broaden consumer benefits if a significant publisher partnership materializes. We'll review what Citron Research's focus on a possible major customer announcement might mean for Cardlytics'...

Deciding whether to stay invested in or take a fresh look at East West Bancorp is on the minds of many savvy investors right now. With a closing price of $108.36, the stock has delivered gains that outpace much of the broader market, jumping 14.7% year-to-date and an impressive 36.2% over the last 12 months. If you have been watching the steady climb, including a remarkable 265.9% over the past five years, it is worth asking whether the current price offers more room to run or signals a time...

Trying to figure out what to do with Astera Labs stock? You are not alone. With prices leaping nearly 47% year-to-date and soaring a staggering 269.5% over the past year, this stock is on the radar of everyone from retail investors to seasoned pros. However, it has not been a straight shot up. Over the last week, Astera Labs fell 19.3%, signaling that market confidence can waver quickly and risk perceptions may be shifting. In the past month, though, there was a rebound of 10.4%, showing an...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...